Feed aggregator

AACR 2024: What Cancer Researchers Are Talking About

Biospace news - Fri, 10/04/2024 - 02:00
AACR 2024: What Cancer Researchers Are Talking About 4/10/2024

PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC

Biospace news - Sat, 09/07/2024 - 02:00
PBMs ‘Wield Enormous Power’ Over Patient Access to Affordable Drugs: FTC 7/9/2024

Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study

Biospace news - Sat, 09/07/2024 - 02:00
Lilly’s Mounjaro Helps Patients Lose More Weight Than Novo’s Ozempic: Study 7/9/2024

House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year

Biospace news - Sat, 09/07/2024 - 02:00
House Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year 7/9/2024

Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D

Biospace news - Sat, 09/07/2024 - 02:00
Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D 7/9/2024

FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication

Biospace news - Sat, 09/07/2024 - 02:00
FDA CBER Director Dr. Peter Marks Discusses Industry Growth, Collaboration and Communication 7/9/2024

US Government Files Appeal in High-Stakes HIV PrEP Patent Battle Against Gilead

Biospace news - Sat, 09/07/2024 - 02:00
US Government Files Appeal in High-Stakes HIV PrEP Patent Battle Against Gilead 7/9/2024

What Does Wegovy’s Launch in China Mean as Biosimilar Competition Emerges?

Biospace news - Sat, 09/07/2024 - 02:00
What Does Wegovy’s Launch in China Mean as Biosimilar Competition Emerges? 7/9/2024

Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall

Biospace news - Sat, 09/07/2024 - 02:00
Roche Reintroduces Wet AMD Eye Implant Nearly Two Years After Voluntary Recall 7/9/2024

UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data

Biospace news - Sat, 09/07/2024 - 02:00
UniQure Wins First FDA RMAT in Huntington’s Disease After Strong Phase I/II Data 7/9/2024

Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs

Biospace news - Thu, 09/05/2024 - 02:00
Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs 5/9/2024

Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024

Biospace news - Thu, 09/05/2024 - 02:00
Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024 5/9/2024

Women's Health: Where Politics and Science Meet

Biospace news - Thu, 09/05/2024 - 02:00
Women's Health: Where Politics and Science Meet 5/9/2024

Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies

Biospace news - Thu, 09/05/2024 - 02:00
Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies 5/9/2024

Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds

Biospace news - Thu, 09/05/2024 - 02:00
Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds 5/9/2024

Bespoke Gene Therapy Consortium Targets AAVs for Rare Diseases

Biospace news - Thu, 09/05/2024 - 02:00
Bespoke Gene Therapy Consortium Targets AAVs for Rare Diseases 5/9/2024

Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop

Biospace news - Thu, 09/05/2024 - 02:00
Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop 5/9/2024

DEIB Evolves As Criticism, Changing Attitudes Continue

Biospace news - Thu, 09/05/2024 - 02:00
DEIB Evolves As Criticism, Changing Attitudes Continue 5/9/2024

Dry Promotions: Dealing With a Double-Edged Sword

Biospace news - Thu, 09/05/2024 - 02:00
Dry Promotions: Dealing With a Double-Edged Sword 5/9/2024

Top 5 Companies Hiring in the Boston Area

Biospace news - Thu, 09/05/2024 - 02:00
Top 5 Companies Hiring in the Boston Area 5/9/2024